Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US

IMPORTANCE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduce deaths from cardiovascular conditions, hospitalizations for heart failure, and progression of kidney disease among patients with type 2 diabetes. Black individuals have a disproportionate burden of cardiovascular and...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberly, Lauren A., Yang, Lin, Eneanya, Nwamaka D., Essien, Utibe, Julien, Howard, Nathan, Ashwin S., Khatana, Sameed Ahmed M., Dayoub, Elias J., Fanaroff, Alexander C., Giri, Jay, Groeneveld, Peter W., Adusumalli, Srinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050743/
https://www.ncbi.nlm.nih.gov/pubmed/33856475
http://dx.doi.org/10.1001/jamanetworkopen.2021.6139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050743/
https://www.ncbi.nlm.nih.gov/pubmed/33856475
http://dx.doi.org/10.1001/jamanetworkopen.2021.6139

Ejemplares similares